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Choline loss during hemodialysis: Homeostatic control of plasma
choline concentrations. Endogenous concentrations of free choline
in plasma were measured in azotemic subjects receiving repetitive
hemodialysis and excretion of free choline into the dialysate was
determined. Chemical choline in plasma and dialysate was meas-
ured by adding choline kinase and measuring the production of
radiolabelled phosphorycholine in the presence of radiolabelled
adenosine triphosphate (ATP). Mean free choline concentration in
plasma of azotemic subjects receiving hemodialysis was found to
be 37 MM, which is about twice that of normal persons. The total
excretion of choline into the dialysate during 360 mm averaged 730
Mmoles 69 (sEM). Levels of free choline in plasma fell during
hemodialysis at two hours but recovered toward predialysis values
at six hours. The return of plasma choline concentrations toward
control values during dialysis suggests that a feedback mechanism
exists which was activated rapidly to produce homeostasis of
plasma choline concentrations. In these patients, the degree of
peripheral neuropathy as judged by measurement of nerve con-
duction velocities showed a significant inverse correlation with
levels of free choline in plasma.
Perte de choline su cours de l'hémodialyse: Contrôle homéosta-
tique de Ia concentration plasmatique de choline. La concentration
plasmatique de choline libre endogène a été mesurée chez des sujets
atteints d'urémie soumis a I'hemodialyse chronique et l'exrétion
de choline libre dans Ic dialysat a été évaluée. La choline du plasma
et du dialysat a été mesurée par l'addition de choline-kinase radio-
active en presence d'ATP marquee. La concentration plasmatique
moyenne de choline libre chez les sujets atteints d'urCmie et soumis
a l'hémothalyse est de 37 MM, c'est-à-dire environ Ic double des
sujets normaux. L'excrétion totale de choline dans Ic dialysat en
360 minutes est de 730 Mmoles+ 69 (SE). La concentration plasma-
tique de choline libre est abaissée a Ia deuxième heure de
l'hCmodialyse mais revient vers les valeurs antCrieures a Ia dialyse a
Ia sixième heure de celle-ci. Ce retour suggCre l'existence d'un
mécanisme de feedback rapidement active qui realise une home-
óstasie de Ia concentration plasmatique de choline. Chez ces mal-
ades l'intensité de Ia neuropathie périphCrique, apprCciée par Ia
vitesse de conduction nerveuse, montre une correlation inverse
significative avec Ia concentration de choline fibre du plasma.
Recently there has been a great deal of interest in
the metabolism of vitamins, amino acids and trace
metals in the chronic uremic state [I]. Many patients
receiving repetitive hemodialysis have been shown to
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have deficiencies in or altered metabolism of these
essential nutrients, vitamin B6 being an example.
Choline is a biocation having roles in several vital
physiologic processes. Firstly, it is phosphorylated by
choline kinase and enters cell membrane structures as
phospholipid. Secondly, oxidized to betaine in the
liver and kidney, it serves as an important methyl
donor. Thirdly, plasma free choline enters neuron
sites, where choline acetyltransferase catalyses its in-
corporation into the neurotransmitter, acetylcholine.
Endogenous concentrations of free choline in plasma
are maintained within a range of 10 to 20 zM in
several species in health [2, 31. The concentration of
free choline in plasma determines the rate of produc-
tion of the neurotransmitter acetyicholine in brain [4]
and ganglia [5]. It has been observed by several in-
vestigators that injected choline disappears extremely
rapidly from the circulation [6—8]. The mechanisms
which are involved in this homeostasis of free choline
in plasma are not well understood. It has now be-
come clear that the kidney plays an important role in
this regulatory system [8—10].
Peripheral neuropathy is a common complication
of the chronic uremic state. In view of the vital role of
kidneys in choline homeostasis and the important
role of choline in cell membrane and neurotransmit-
ter function, we have studied the clearance of choline
and the homeostatic response of the plasma choline
concentrations in uremic patients who are receiving
repetitive hemodialysis treatment. Preliminary results
have been published [11].
Methods
Dialyses. For most of the data presented, a Tray-
enol RSP hemodialysis machine was used. The recir-
culation was prevented and dialysate was siphoned
off, collected and frozen during the study periods.
The EXO-3 dialysis coil was used, except in three of
the nine hemodialysis studies, where the disposable
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Gambro-Lundia dialyzer (17 layers) was used by
means of a Drake-Willock proportioning delivery
system. Since clearances were not significantly differ-
ent between the two types of dialyzers, data have
been pooled. Both these dialyzers had surface areas
around lm2. Unless otherwise stated, all studies were
carried out with a constant blood flow of around 200
mI/mm while the dialysate flow during the studies
was kept at about 400 mI/mm for both types of
dialyzer. All patients were having six-hour hemo-
dialysis runs three times a week and were ambu-
latory. All patients were on an oral regimen of alumi-
num hydroxide gel (Amphojel), folic acid (1 mg daily)
and a multivitamin preparation not containing any
choline. Some of the patients were also receiving
other drugs such as digoxin, antihypertensives, laxa-
tives and hypnotics, but none of the patients were on
any drug containing free choline. All patients were on
a diet containing 60 to 80 g of protein per day without
any other restrictions. Patients with abnormalities in
liver function or hepatomegaly and patients with a
systemic disease such as chronic congestive heart fail-
ure or systemic lupus erythematosus were excluded
from the study.
Standard techniques were used for peritoneal
dialyses involving 2-liter cycles of 1.5% Dineal (Ab-
bott Laboratories) with 3 mEq/liter of KC1 added.
Usually the patients received 36 hr of dialysis per
week divided into three sessions. Equilibration time
was 20 mm, the cycle being usually completed in an
hour. The patients studied were on the repetitive
peritoneal dialysis program and did not have func-
tional liver impairment. They were on dietary and
drug management similar to those receiving repetitive
hemodialysis.
Choline analysis. Blood samples were drawn from
the arterial side entering the dialyzer, from the ef-
fluent and from peripheral veins. Cells were removed
immediately and the plasma was frozen. Samples of
dialysate were collected either from the fluid leaving
the dialyzer or from the entire dialysis fluid which
was collected and pooled. Samples were frozen until
assayed. Choline analysis was performed on 1 or 2l
of plasma, and 5 1 of dialysate or urine directly
without extraction. An enzymatic radiochemical as-
say was used to determine free choline [9, 121. Cho-
line in the sample is converted to 32P-phosphorylcho-
line in the presence of added choline kinase and 32P-
adenosine triphosphate (ATP). The assay has a sensi-
tivity such that 10 pmoles of choline are equal to
three times the enzyme blank of the assay. Quad-
ruplicate determinations were performed on each
sample, two of which contained added standard cho-
line to monitor recovery of the sample. The coefficient
of variation (i.e., the sample estimate of the SD ex-
pressed as a percent of the quantity of choline being
analyzed) was approximately 5% at the 100 to 200
pmole level and increased with decreasing choline
quantity according to the equation CV = 4.7 +
51
. Thus, at 40 pmoles the coefficientquantity of choline
of variation was about 6%; at 20 pmoles, about 10%
and at 5 pmoles, about 15%. Statistical analyses are
presented as means SEM in all cases except nerve
conduction velocities.
Other. Nerve cond.uction velocities (NCV's) were
measured in the peroneal nerves and expressed as
meters per second (m/sec). An electrical current of
100 v was applied for up to 0.5 msec on the peroneal
nerves at the lateral side of the upper end of the fibula
while the recording electrode was applied on the ex-
tensor digitorum brevis muscle. The mean value for
NCV's for normal persons in our hospital was 45.6
m/sec 2.1 (SD). The range was 42 to 49 m/sec. Only
patients who had no significant differences (less than
5%) between the NCV's of right and left peroneal
nerves were included in this study. The values re-
ported are the mean of the right and left peroneal
NCV.
Standard techniques were used for all routine bio-
chemical determinations.
Results
Renal clearance of choline in normal man. The
urinary clearance of choline was measured in five
subjects with normal renal function. The mean clear-
ance value was 1.9 ml/min or 0.032 + 0.019 mI/kg.
mm. This value is comparable to the choline renal
clearance in dogs and chickens, previously found to
be between 0.02 and 0.03 ml/kg.min [9].
Levels of free choline in plasma in nonuremic
patients compared with chronicuremic patients before
and during hemodialysis. The mean value for the con-
centration of free choline in the plasma of nonuremic
patients was 13.4 2.01 mrvi. A group of uremic
patients being observed in the hospital who had never
undergone dialysis had a mean value of 20.8 1.65
mM. Uremic patients undergoing repetitive mainte-
nance hemodialysis had a mean value for plasma
choline of 32.5 1.8 m when measured before the
patient was connected to the dialyzer. These values
are shown on Table 1.
Choline losses during extracorporeal hemodialysis.
In a series of six uremic patients undergoing extra-
corporeal dialysis for 150 mm, the mean choline
clearance into the dialysate was found to be 69.2
14.9 mI/mm (Table 2). The mean loss of choline into
the dialysate was found to be 1.8 moles/min.
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Table I. Concentration of free choline in human plasma
Choline, M
Systemic venous
plasma
Arterial
plasma
Nonuremics 13.4 2.01 (5) 14.3 + 0.95 (9)
Uremics, never dialyzed 20.8 1.65 (7)"
Uremics, after repetitive 32.5 1.8 (25) 30.4 1.93 (22)d
dialysis therapy
Parentheses indicate the number of observations.
Compared with nonuremic (P < 0.05).
Compared with uremics before dialysis (P < 0.005).
Compared with nonuremics (P < 0.00005).
In order to shed further light on the time kinetics of
choline losses in hemodialysis, more extensive studies
were then performed during nine extracorporeal
hemodialyses for six hours. As can be seen in Table 3,
choline enters the dialysate from plasma at progres-
sively increasing rates until about 120 mm after com-
mencement of dialysis. At this time, there was a level-
ling off of the rate of loss into dialysate as well as in
the concentration in the dialysate. Arterial plasma
choline concentration fell to about 73% of the control
value at this time, while blood returning to the body
from the hemodialysis (plasma efferent) had a choline
concentration of about 66% of that in the blood
entering the hemodialysis coil (Fig. 1). The concen-
tration of choline in the dialysate after establishment
of steady state following 120 mm of dialysis was
always less than 50% of that in the efferent blood
from the coil.
The mean clearance of choline into the dialysate
was 71.5 3.3 mI/mm. The total loss of choline from
Table 2. Endogenous plasma choline clearance into dialysate
during 150 mm of hemodialysisa
Choline clearance, mi/mm 69.2 + 14.9
Control: arterial plasma choline, M 25.7 3.3
After dialysis:
arterial plasma choline, .tM 22.0 1.8
Choline loss into dialysate,
zmoles total 272.0
Choline loss, Mmoles/min 1.8
The values represent means SEM for six hemodialyses in six
uremic patients.
the body amounted to a mean of 730 69 imoles in
six hours or 2.0 pmo1es/min.
Although the choline concentration in arterial
blood falls at 120 mm to 73% of the value before
commencement of dialysis, arterial choline concen-
trations tend to rise toward the predialysis value after
120 mm (Table 3 and Fig. 2). Thus, the arterial
choline concentrations at 240 and 360 mm show a
progressive rise, although full restoration to the pre-
dialysis value is not achieved. This tendency towards
restoration of plasma concentrations is thus accom-
plished despite continuing losses of choline into the
dialysate suggesting the operation of homeostatic
mechanisms.
Choline losses during peritonea! dialysis. Choline
clearance into dialysate was measured in each of two
patients who were undergoing repetitive peritoneal
dialysis. Plasma choline concentrations were un-
changed throughout. The mean rate of choline excre-
tion was 0.46 tmoles/min and the mean rate of cho-
line clearance was 28.5 ml/min. These data suggest
that the choline clearance during peritoneal dialysis is
Table 3. Endogenous p1asma choline clearance into dialysate during hemodialysisa
Dialysis Choline
Choline, tM
Choline CholineCoil Peripheral
duration clearance Arterial plasma venous excretion extraction
mm mi/mm plasma efferent plasma Dialysate jAmoles/min from plasma"
Before
0 36.9 1.9 36.6 + 1.2
During
10 3.0+0.65 1.2
30 4.1 +0.46 1.5
60 5.1 0.56 1.9
120 69.0 7.7 27.0 + 1.2' 14.8 1.5 5.8 0.63 2.1 0.43 + 0.074
240 78.1 + 9.0 28.3 1.9 14.2 + 1.7 6.0 + 0.73 2.1 0.49 + 0.057
360 67.3 + 6.6 31.9 2•3d 17.7 3.6 6.1 0.98 2.1 0.52 + 0.054
After
Immediately 31.4 + 2.0
6 hr 33.2 3.2
18 hr 32.5 3.2
a Each value is the mean + SEM of nine hemodialyses in four uremic patients. Total choline excreted into dialysate = mean 730 imoles + 69
or 2.0 tmoles/min.
b Choline extraction =
Artery,s,,,,e — Coil efTerent,oi,ne
Artery,so,,ne
Compared with 0 time, P = 0.02.
Compared with 120 mm, P < 0.1.
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Fig. 1. Plasma concentration of free choline described in the blood
entering and leaving the dialyzer and in the dialysale leaving the
dialyzer. Choline clearance = 71.5 mI/mm; choline excretion =
730 jAmoles/6 hr; artery-vein = 12 M; vein-dialysate = 9 /M.
considerably slower than that during extracorporeal
hemodialysis, and homeostatic mechanisms success-
fully preserve plasma concentrations despite losses
into dialysate.
Choline clearance with varying bath flow. The ef-
fects of progressive increase in dialysate flow are de-
picted in Fig. 3. In three patients, an increase in
dialysate flow from 100 to 400 ml/min resulted in a
progressive increase in choline clearance into dialy-
sate. However, at all rates of dialysate flow, the cho-
line clearance was always below simultaneous creati-
nine and urea clearances. Similar studies, while
progressively increasing blood flow, were not done in
40 -
120 240
Duration of hemodialysis, rn/n
Fig. 2. The response of the choline concentration in arterial plasma
displayed during six hours of hemodialysis. The values are the mean
+ SEM of nine uremic patients.
200 300 400
Bath flow, rn//rn/n
Fig. 3. Choline clearance from blood into dialysate measured as
dialysate bath flow was progressively increased from 100 rnl/min to
200 and then 400. Simultaneous urea and creatinine are described.
Values are the means of three uremic patients.
view of incidence of patient symptoms above blood
flow rates of 300 mI/mm in our unit.
Renal extraction of choline. In nine patients under-
going renal angiography, choline concentrations were
measured in renal arterial and renal venous blood.
These kidneys extracted about 30% of the choline
entering the artery (Table 4). Concurrent experiments
in dogs in our laboratory (unpublished observations)
have indicated a similar rate of renal extraction of
choline.
Correlation of plasma choline concentrations with
severity of neuropathy. Figure 4 depicts the relation of
peroneal nerve conduction velocity to plasma choline
concentrations in 18 azotemic patients receiving re-
petitive extracorporeal hemodialysis. It can be seen
that nerve conduction velocity was inversely related
to plasma choline concentration. Statistical eval-
Choline, jAM Renal choline extraction
Right Left
renal renal (A-RRV/A) (A-LLV/A)
Patient Arterial vein vein X 100 X 100
No. (A) (RRV) (LRV)
I 11.8 7.8 8.5 34 28
2 19.2 12.3 12.3 36 363 17.7 — 11.6 — 344 16.0 11.4 — 29 —5 11.8 8.8 — 25 —
6 15.5 10.0 11.1 36 28
7 12.7 — 10.1 — 208 12.5 9.7 — 22 —9 11.8 7.1 — 39
Mean,
31.6 2.40
—
29.2 + 2.79
Dialysate
cbArteryp
27 JAM
Vein
15 4UM E
ci
5,
0
0
' Creatinine
o Urea
• Choline120 -
80 -
40-
0 100
1
1
+ I
a.
30C
0
-C0
5,t
20
0
TbIe 4. Renal extraction of choline in nonuremic patients
0 360
Only one side studied for choline because of nonfunction of
other kidney.
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uation by regression analysis revealed a correlation
coefficient of r =
—0.7; P < 0.01. There was no
significant correlation between either blood urea ni-
trogen (BUN) or serum creatinine concentration and
the nerve conduction velocity.
Discussion
These studies on azotemic patients receiving
maintenance hemodialysis have measured the loss of
choline into the dialysate and the response of the
plasma choline concentration to the dialysis pro-
cedure. It is becoming clear from animal studies that
homeostatic mechanisms maintain a constant level of
free choline in plasma in health in the range of 10 to
20 iM in several species, showing little variation in
response to strenuous exercise, ingestion of food,
moderate choline loading and choline depletion [2,
3]. Injected choline disappears unusually rapidly
from the circulation [6—8].
The kidney plays a major role in the regulation of
the level of free choline in plasma. Choline is freely
filterable at the glomerulus. Choline is a cation with a
mol wt of 103 and a pK of 13.9. In the usual state of
choline balance, a major fraction of the filtered cho-
line is removed from the tubular lumen by active
reabsorption so that renal clearance of choline is only
1/30th that of inulin clearance [9]. If plasma choline
concentrations are elevated by exogenous infusion,
net tubular excretion of choline commences when the
plasma level doubles [8]. At the most, about two-
thirds of the infused choline may be excreted by the
kidneys. The tubular transport maximum (Tm) for
choline is only exceeded by infusion of choline at
rates calculated to produce more than a tenfold eleva-
tion of peritubular plasma choline [13].
In these present experiments the homeostatic regu-
lation of plasma choline was studied in the presence
of impaired renal function and with the added pro-
cedure of hemodialysis. The two major findings in
these studies were an elevated concentration of
plasma choline in the control state and a loss of
choline into the dialysate accompanied by an acute
fall in plasma concentrations of free choline with
compensatory mechanisms beginning during the pe-
riod of hemodialysis.
The elevated plasma choline concentration in
uremic patients undergoing hemodialysis may seem a
bizarre finding in the face of the acute net loss of
choline from the body. Although no mechanisms have
been proven, several suggestions for this elevation
can be made. Firstly, the diseased kidney may be
unable to metabolize choline at the normal rate and
thus more free choline remains in the plasma. The
present studies showed that the nonuremic human
kidney extracts about 30% of the choline offered to it
at normal levels of plasma choline. The urinary clear-
ance of choline is only 1.9 ml/min, yet the kidney
clearance (extraction) is 30% of the renal plasma
flow. The uremic kidney may have an impaired ca-
pacity to metabolize choline and this could result in
an elevated concentration of free choline in the
plasma. It is not possible to catheterize the renal vein
in uremic humans for such data. Although we have
observed the same rate of renal extraction of choline
in normal dogs, we have not studied uremic dogs. We
have observed that dog kidneys will extract a similar
percent of choline even when the arterial concentra-
tion of choline is elevated several-fold. It remains a
possibility that the renal extraction and metabolism
of choline play a significant role in regulating the
level of plasma choline. Secondly, the uremic state
may alter the feedback mechanisms in such a way
that the regulatory sensors of the homeostatic system
are set to produce a higher operating concentration
40
20
.
E
>0z
40
Fig. 4. Relation of nerve conduction velocity to plasma choline in a
group of uremic patients undergoing repetitive hemodialysis. The
correlation coefficient is —0.7! with P < 0.0!. The peroneal nerve
conduction velocity (NCV) showed a mean value for normal per-
Sons tfl this hospital of 45.6 rn/sec 2.! (SD) with a range of 42 to
49 rn/sec.
0 20
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of plasma choline. Thirdly, the uremic state may
result in metabolic alterations that affect the in-
corporation of free choline into the neurotransmitter
acetylcholine or into membranes.
It has been found that trimethylamine (TMA) and
dimethylamine (DMA) concentrations are elevated
in uremics [16]. There is the possibility that these
metabolic products of choline, formed in the gut by
bacterial action, may have a role in uremic toxicity.
The finding of an elevated level of free choline in
plasma of uremics in the present studies may offer an
explanation for the elevated metabolites TMA and
DMA, found by Simenhoff in uremia [16].
One of the major findings in this study is the dem-
onstration that the homeostatic regulatory system is
activated during the course of the six hours of
dialysis. The plasma choline concentration showed a
consistent fall during the first two hours of hemo-
dialysis. Choline was lost into the dialysate at a rate
of 2.0 moles/min and the organism could not com-
pensate immediately for this loss. One might expect
any of the following to occur at the cellular level as a
result of this acute depletion of choline from the
plasma: an alteration of acetylcholine formation,
metabolic changes related to the methyl donor func-
tion of choline, and structural changes in membranes
related to choline incorporation.
Although plasma choline concentrations fell dur-
ing dialysis, these levels were gradually restored to-
ward predialysis values during the six hours of
dialysis, despite continued choline losses into the
dialysate. The rise of levels of free choline in plasma
during continued dialysis points to a highly effective
and rapidly responding honieostatic mechanism that
defends plasma concentrations in response to acute
depletional stress.
Feldman and Singer [1] have recently reviewed the
numerous metabolic and endocrine alterations asso-
ciated with uremia. Repetitive dialysis improved
some abnormalities but created others, perhaps by
removing vital biological fuels or by disrupting meta-
bolic rates or feedback control mechanisms. They
presented data to show that the plasma concentration
of several biogenic substrates was elevated in uremia
and by hemodialysis.
There is direct evidence that the concentration of
choline in the plasma directly regulates the formation
of acetylcholine in brain [4], and in the isolated per-
fused ganglia [5]. It is reasonable to expect that os-
cillations in plasma choline are capable of producing
major changes in neurotransmitter activities related
to acetylcholine. Since one-half of patients under-
going hemodialysis demonstrate neuropathies [15], it
seems reasonable that functional nerve defects could
accompany the changes in choline resulting from ei-
ther uremia or hemodialysis. The vital role of choline
in the production of the neurotransmitter acetyl-
choline and its role in regulating the structure of the
neural membrane suggests that choline availability
could influence the neuropathy of uremia and
dialysis. In the light of these facts, our observation of
the significant correlation between elevation in
plasma choline concentrations with the degree of im-
pairment in peroneal nerve conduction is of interest.
We must caution at the same time that the evidence at
hand does not support or prove that one is in any way
causally related to the other. Even so, our observa-
tions do raise the possibility that altered homeostasis
of choline in the uremic state may, in part, contribute
to the development of the peripheral neuropathy and
central nervous system dysfunctions that are ob-
served in azotemic patients receiving repetitive hemo-
dialysis.
Retention of substances in the mol wt range of 400
to 5000 ("middle molecules") has been proposed in
the pathogenesis of many metabolic and clinical al-
terations characteristic of the azotemic state and par-
ticularly for neuropathy. Recently, it has also been
pointed out that there are many substances belonging
to the "middle molecule" range that are elements of
vital importance to the organism, including amino
acids, vitamins and hormones [1]. Thus, while hemo-
dialysis does improve certain metabolic derange-
ments, it is possible that it may create others by
depletion of vitally important elements, or by stress-
ing normal feedback control mechanisms and dis-
ruption of established metabolic turnover rates.
Kjellstrand et al have stressed that once a patient is
accepted into a dialysis program, the "unphysiology"
of dialysis may be a major determinant of the side
effects of dialysis [14]. Is the loss of choline into the
dialysis one of these "unphysiologic" effects? Is the
acute oscillation of the level of free choline during
hemodialysis providing misleading signals to the
feedback systems which attempt to regulate the turn-
over of free choline in the body?
While not belonging to the "middle molecule"
class, choline may serve as an example of an impor-
tant biological element which is acutely depleted
from the body during each hemodialysis treatment
and, in response, homeostatic mechanisms are rap-
idly activated in the uremic patient receiving hemo-
dialysis.
Such a clear demonstration of a feedback control
system will provide an area for further studies to
attempt to determine the mechanisms involved in this
homeostatic control of plasma choline concentra-
tions.
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